Health Care Utilization and Costs in Systemic Therapies for Metastatic Melanoma from 2016 to 2020

By sjmartinez • October 28, 2022

Qian MF, Betancourt NJ, Pineda A, Maloney NJ, Nguyen KA, Reddy SA, Hall ET, Swetter SM, Zaba LC. Health Care Utilization and Costs in Systemic Therapies for Metastatic Melanoma from 2016 to 2020. Oncologist. 2022 Oct 27:oyac219. doi: 10.1093/oncolo/oyac219. Epub ahead of print. PMID: 36302223.

Tags: administrative claims, Dermatology, healthcare, Healthcare cost, immune checkpoint inhibitors, melanoma, molecular targeted therapy, Publications

Hot Topics: Exploring Artificial Intelligence and Inflammatory Memory in the Management of Psoriatic Diseases

Shucheng H, Armstrong AW, Eidsmo L, Poddubnyy D. Hot Topics: Exploring Artificial Intelligence and Inflammatory Memory in the Management of Psoriatic Diseases. J Rheumatol. 2025[...]

Report of the IDEOM Meeting Adjacent to the GRAPPA 2024 Annual Meeting

Romanelli S, Childs B, Strand V, Armstrong AW, Perez-Chada LM, Merola JF, Gottlieb AB. Report of the IDEOM Meeting Adjacent to the GRAPPA 2024 Annual[...]

Whole genome sequence of the syntrophic benzoate-degrading bacterium, Syntrophus buswellii DSM 102354T

Gunsalus RP, Humm E, Cook L, Wofford NQ, James KL, Pellegrini M, Morselli M, Ha SM, McInerney MJ. Whole genome sequence of the syntrophic benzoate-degrading[...]